


To provide long-term capital growth from investment in stocks and shares.
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell | 7.7% |
| BP | 7.0% |
| HSBC | 6.0% |
| GlaxoSmithKline | 5.3% |
| AstraZeneca | 4.0% |
| Vodafone | 3.9% |
| Barclays | 2.4% |
| BHP Billiton | 2.3% |
| JPM UK Smaller Companies Fund | 2.2% |
| Reckitt Benckiser | 2.1% |
| Key | % Net Assets |
|---|---|
| 7.7% | |
| 7.0% | |
| 6.0% | |
| 5.3% | |
| 74% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 09/11/1982 |
|---|---|
| Fund Manager | Michael Barakos / David Allen |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | 100 |
| Savings | 100 |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.04 |
You are here: research